Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Anumigilimab by CSL for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Anumigilimab is under clinical development by CSL and currently in Phase I for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...
Data Insights
Anumigilimab by CSL for Sickle Cell Disease: Likelihood of Approval
Anumigilimab is under clinical development by CSL and currently in Phase I for Sickle Cell Disease. According to GlobalData, Phase...